Bespoke Extracts (BSPK) Current Leases (2022 - 2025)

Bespoke Extracts (BSPK) reported Current Leases of $52650.0 for Q3 2025, down 28.39% on a YoY basis from $73523.0 in Q3 2024, and down 11.29% sequentially from $59353.0 in Q2 2025.

Bespoke Extracts (BSPK) Current Leases (2022 - 2025) Analysis & Trends

Bespoke Extracts (BSPK) has 4 years of Current Leases data on file, last reported at $52650.0 in Q3 2025.

  • For the quarter ending Q3 2025, Current Leases fell 28.39% year-over-year to $52650.0; the trailing twelve-month figure through Sep 2025 stood at $52650.0 (down 28.39% YoY), and the FY2024 full-year result was $73523.0, up 14.29% from the prior year.
  • Current Leases declined to $52650.0 in Q3 2025, from $59353.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $73523.0 in Q3 2024 to a low of $38063.0 in Q1 2025.
  • A 4-year average of $62388.5 and a median of $64330.0 in 2022 frame the typical range for Current Leases.
  • Across the five-year window, Current Leases increased 14.29% in 2024 and plunged 40.83% in 2025, its largest moves.
  • Tracing BSPK's Current Leases over 4 years: stood at $64330.0 in 2022, then changed by 0.0% to $64330.0 in 2023, then gained by 14.29% to $73523.0 in 2024, then dropped by 28.39% to $52650.0 in 2025.
  • Business Quant data shows BSPK's Current Leases at $52650.0 in Q3 2025, $59353.0 in Q2 2025, and $38063.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Bespoke Extracts 1.12 Mn 1.11 Mn 234,175.00 52,650.00

Historic Data

Download Data
DateValue
Sep 30, 2025 52,650.00
Jun 30, 2025 59,353.00
Mar 31, 2025 38,063.00
Dec 31, 2024 73,523.00
Sep 30, 2024 73,523.00
Jun 30, 2024 64,330.00
Mar 31, 2024 64,330.00
Dec 31, 2023 64,330.00
Sep 30, 2023 64,330.00
Jun 30, 2023 64,330.00
Mar 31, 2023 64,330.00
Dec 31, 2022 64,330.00
Sep 30, 2022 64,330.00
Jun 30, 2022 62,797.00
Mar 31, 2022 61,279.00